...
首页> 外文期刊>Inflammation & allergy drug targets. >Scleroderma renal crisis accompanied by new-onset pulmonary arterial hypertension: an acute systemic endothelial injury? Case report and literature.
【24h】

Scleroderma renal crisis accompanied by new-onset pulmonary arterial hypertension: an acute systemic endothelial injury? Case report and literature.

机译:硬皮病肾危象伴发新发性肺动脉高压:急性全身内皮损伤?病例报告和文献。

获取原文
获取原文并翻译 | 示例
           

摘要

Systemic Sclerosis (SSc) is a multisystem connective tissue disease characterized by fibrosis of the skin and internal organs and extensive vasculopathy. We report a case of a 41 year-old white woman with a 10 year-history of limited scleroderma, who developed the rare combination of Scleroderma Renal Crisis (SRC) and Systemic Sclerosis related Pulmonary Arterial Hypertension (SScPAH) in the same time. Although the patient received the proposed antihypertensive treatment, the renal function did not recover, and she initiated on renal replacement therapy. SRC and SScPAH are two aspects of SSc vasculopathy characterized by endothelial dysfunction mediated by endothelin-1 and other vasoactive hormones. Further new studies with therapies directed towards the underlying mechanisms of SRC (i.e. endothelin-receptor antagonists), which are proven helpful in SScPAH, should take place to establish new therapeutic options and improve prognosis of these patients, for which our therapeutic armamentarium is currently poor.
机译:系统性硬化症(SSc)是一种多系统结缔组织疾病,其特征在于皮肤和内部器官的纤维化以及广泛的血管病变。我们报告了一例41岁白人妇女,患有有限性硬皮病已有10年的历史,她同时发展了罕见的硬皮病肾病危象(SRC)和系统性硬化相关性肺动脉高压(SScPAH)的组合。尽管患者接受了建议的降压治疗,但肾功能并未恢复,她开始进行肾脏替代治疗。 SRC和SScPAH是SSc血管病变的两个方面,其特征是内皮素1和其他血管活性激素介导的内皮功能障碍。经证实对SScPAH有帮助的针对SRC潜在机制(即内皮素受体拮抗剂)的疗法的进一步新研究应建立新的治疗选择并改善这些患者的预后,而目前我们的治疗装备还很差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号